X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11131) 11131
Book Review (1279) 1279
Publication (796) 796
Book Chapter (56) 56
Conference Proceeding (28) 28
Dissertation (7) 7
Magazine Article (4) 4
Presentation (4) 4
Book / eBook (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8393) 8393
ophthalmology (7468) 7468
humans (7259) 7259
intravitreal injections (5527) 5527
male (4992) 4992
female (4694) 4694
aged (3437) 3437
bevacizumab (3213) 3213
middle aged (3212) 3212
ranibizumab (2869) 2869
vascular endothelial growth factor a - antagonists & inhibitors (2606) 2606
macular degeneration (2404) 2404
tomography, optical coherence (2274) 2274
treatment outcome (2265) 2265
angiogenesis inhibitors - therapeutic use (2060) 2060
intravitreal injection (2029) 2029
retrospective studies (1966) 1966
angiogenesis inhibitors - administration & dosage (1949) 1949
aged, 80 and over (1876) 1876
visual acuity (1842) 1842
animals (1817) 1817
fluorescein angiography (1778) 1778
eye diseases (1729) 1729
endothelial growth-factor (1613) 1613
visual acuity - physiology (1595) 1595
follow-up studies (1582) 1582
vascular endothelial growth factor (1548) 1548
adult (1461) 1461
macular edema - drug therapy (1412) 1412
genetic structures (1321) 1321
retina (1255) 1255
injection (1242) 1242
diabetic retinopathy (1195) 1195
prospective studies (1183) 1183
intravitreal bevacizumab (1168) 1168
sense organs (1070) 1070
care and treatment (1039) 1039
macular edema (1036) 1036
optical coherence tomography (1014) 1014
choroidal neovascularization - drug therapy (966) 966
choroidal neovascularization (944) 944
injections (898) 898
antibodies, monoclonal, humanized - therapeutic use (883) 883
vitrectomy (872) 872
photodynamic therapy (858) 858
therapy (852) 852
age-related macular degeneration (843) 843
diabetic retinopathy - drug therapy (843) 843
wet macular degeneration - drug therapy (836) 836
antibodies, monoclonal, humanized - administration & dosage (833) 833
diabetic macular edema (812) 812
medicine & public health (801) 801
antibodies, monoclonal, humanized (796) 796
edema (796) 796
macular degeneration - drug therapy (775) 775
neovascularization (769) 769
triamcinolone (758) 758
pharmacology & pharmacy (753) 753
surgery (733) 733
retinopathy (732) 732
analysis (728) 728
glucocorticoids - administration & dosage (723) 723
macular edema - etiology (708) 708
eye (690) 690
vitreous body (686) 686
triamcinolone acetonide (671) 671
diabetes (670) 670
time factors (666) 666
endophthalmitis (662) 662
retina - pathology (647) 647
avastin (617) 617
degeneration (608) 608
rabbits (607) 607
research (594) 594
abridged index medicus (585) 585
disease models, animal (584) 584
risk factors (583) 583
drug therapy (558) 558
physiological aspects (554) 554
angiogenesis inhibitors - adverse effects (553) 553
retinal vein occlusion (535) 535
intravitreal triamcinolone (525) 525
patients (523) 523
efficacy (519) 519
intraocular pressure (519) 519
visual acuity - drug effects (518) 518
safety (507) 507
fundus oculi (505) 505
vegf (504) 504
intravitreal (497) 497
macular edema - physiopathology (497) 497
verteporfin (497) 497
retinal vein occlusion - drug therapy (496) 496
antibodies, monoclonal - administration & dosage (477) 477
ranibizumab - administration & dosage (476) 476
macular edema - diagnosis (475) 475
glaucoma (472) 472
rats (459) 459
aflibercept (458) 458
age (458) 458
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10192) 10192
German (311) 311
Korean (222) 222
French (215) 215
Spanish (70) 70
Japanese (28) 28
Russian (28) 28
Chinese (24) 24
Polish (21) 21
Portuguese (19) 19
Czech (14) 14
Romanian (14) 14
Turkish (9) 9
Hungarian (7) 7
Slovenian (2) 2
Swedish (2) 2
Danish (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, ISBN 9789814571463
Intravitreal injections (injections into the eye) are a new form of treatment for various conditions such as age-related macular degeneration, diabetic eye... 
Eye | Vision disorders | Intravitreal Injections | therapy | methods | nursing | Ophthalmology | Eye Diseases | Diseases
Web Resource
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 1/2008, Volume 246, Issue 1, pp. 81 - 87
Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized by macular edema and/or... 
Angiogenesis | Intravitreal bevacizumab | Medicine & Public Health | Choroidal neovascularization | Age-related macular degeneration | Proliferative diabetic retinopathy | Diabetic macular edema | Ophthalmology | Safety | intravitreal bevacizumab | PHOTODYNAMIC THERAPY | choroidal neovascularization | angiogenesis | COHERENCE TOMOGRAPHY FINDINGS | BARRIER | MACULAR DEGENERATION | VERTEPORFIN | PHARMACOKINETICS | safety | PEGAPTANIB | GROWTH-FACTOR APTAMER | OPHTHALMOLOGY | age-related macular degeneration | proliferative diabetic retinopathy | diabetic macular edema | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | BREAKDOWN | Diabetic Retinopathy - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - drug therapy | Bevacizumab | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Time Factors | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Retinal Vein Occlusion - physiopathology | Macular Degeneration - physiopathology | Treatment Outcome | Visual Acuity | Choroidal Neovascularization - physiopathology | Retreatment | Injections | Retinal Vein Occlusion - drug therapy | Macular Edema - physiopathology | Macular Edema - drug therapy | Aged | Endothelial growth factors | Safety and security measures | Angiogenesis inhibitors | Index Medicus
Journal Article
Ophthalmology, ISSN 0161-6420, 01/2014, Volume 121, Issue 1, pp. 193 - 201
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 8/2013, Volume 251, Issue 8, pp. 1885 - 1890
Journal Article
Journal Article
Journal Article
Retina, ISSN 0275-004X, 01/2014, Volume 34, Issue 1, pp. 18 - 23
Purpose: To report on the occurrence of endophthalmitis after intravitreal injections (IVI) in two different settings: office-based and operating room.... 
Retinal vein occlusion | Diabetic retinopathy | Intravitreal injection | Age-related macular degeneration | Ranibizumab | Endophthalmitis | Macular edema | Triamcinolone | Bevacizumab | BEVACIZUMAB AVASTIN INJECTION | FLORA | retinal vein occlusion | MACULAR DEGENERATION | RISK | intravitreal injection | BLEB-ASSOCIATED ENDOPHTHALMITIS | diabetic retinopathy | ANTIMICROBIAL RESISTANCE | ranibizumab | bevacizumab | OPHTHALMOLOGY | GROWTH-FACTOR AGENTS | macular edema | endophthalmitis | OUTCOMES | age-related macular degeneration | triamcinolone | TOPICAL ANTIBIOTICS | Antibodies, Monoclonal, Humanized - adverse effects | Glucocorticoids - administration & dosage | Intravitreal Injections | Humans | Triamcinolone Acetonide - adverse effects | Endophthalmitis - epidemiology | Endophthalmitis - etiology | Incidence | Ambulatory Surgical Procedures - statistics & numerical data | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Wet Macular Degeneration - drug therapy | Retinal Vein Occlusion - drug therapy | Operating Rooms - statistics & numerical data | Macular Edema - drug therapy | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Glucocorticoids - adverse effects | Triamcinolone Acetonide - administration & dosage | Endophthalmitis - drug therapy | Index Medicus
Journal Article